The Walker-256 tumor is an important experimental model that allow the development of therapies as the biological behavior of this tumor is similar that occur in humans. In front of the above considerations, the aim of this study was to describe the experimental model of Walker-256 tumor, identify the implantations sites as well as define a usual quantity of tumoral cells to induce the ascitic and solid tumor, according to the specialized literature. Were selected 45 articles using the keyword "Walker-256 tumor", free available. Were possible to observe that 58% (n=26) of the studies inoculate the tumor cells in the animals flank 33% (n = 15) in the tibia bone, 7% (n = 3) in the femur and 2% (n = 1) in the paw. The major quantitates of cells used were 8 x 10 7 (20%), 1 x 10 5 (13%), 1 x 10 6 (11%) and 2 x 10 7 (11%). After that, the site commonly used to inoculate was the flank and quantitate still a controversy, being 1x10 5 and 8x10 7 the concentrations more used.
INTRODUCTION
Is expected that 14 million of people develop cancer each year, and this number must increase to more than 21 million until 2030. This disease is responsible for almost one in each six deaths worldwide. Each year, 8,8 million of people died from cancer especially in low income countries 1 . Among the causes of death by cancer is cachexia, responsible by 20% of death. This complication in oncologic patients cooperate to a worse prognostic, lower survival, alterations quality of life, deterioration in functional capability, as well as significantly contribute to toxicity induced by chemotherapy 2, 3 . Is known that the conventional treatment for cancer is chemotherapy. However, it case diverse collateral effects and are not efficient in complete remission of tumor. Therefore, several studies are developed searching for new substances that can substitute the conventional method 4, 5, 6, 7, 8, 9, 10, 11 . Thus, it is necessary to use experimental models that corresponds more to the reality of individuals affected by this disease.
Walker-256 tumor is a model that allow this situation. This model is possible to observe the three carcinogenesis stages: initiation, promotion and progression in a brief period of 12-16 days. In addition, the Walker-256 tumor exhibit aggressive biological behavior, locally invasive, with high metastasis capacity 12, 13 . This tumor is used in studies for breast cancer, bone and paw tumors, it has accelerated growth, causing cachexia and oxidative stress, and still has a high metabolic demand, similar to what occurs with cancer patients 14 .
The present study had as objective describe the experimental tumor model Walker-256, identify the implantation sites, as well as define a quantity of usual tumoral cells to induce the ascitic and solid tumor, according to the literature.
MATERIAL AND METHODS
Were included experimental studies that used the tumor model Walker-256 in this review. The search were performed by the Pubmed database, using the keyword: Walker-256. Were considered the articles free available, published between 2012 and July/2018. The exclusion criteria were: (1) do not fit in criteria described above; (2) literature review; (3) case study; (4) retrospective and observational studies; (5) do not describe quantitate of cells used for induce solid tumor.
The search resulted in 1253 articles, to extract the data were evaluated the titles and abstracts of all articles. All abstracts that reported sufficient information according to the inclusion and exclusion criteria were selected. The eligibility step were excluded studies that do not describe the quantity of cells used to induce solid tumor. At the end of assessment, forty studies meet the inclusion and exclusion criteria and were evaluated (Figure 1 ). Were included a few studies that do not meet the criteria, but they are the basis for this theme. 
RESULTS
At this research, were included 45 articles according to the selection criteria described at the material and methods section. In Table 1 are listed the selected articles to the review, with description of quantity of cells used and implantation sites of Walker-256 solid tumor. To analyse the modulatory effect of a leucine-rich diet To investigate the effects of celecoxib and ibuprofen, 
DISCUSSION

History of Walker-256 tumor
George Walker observed firstly in 1928 the Walker-256 tumor spontaneously in the region of mammary gland of a pregnant albino rat, which regressed completely during the lactation period. But it grew again, after the weaning of the offspring. Thus, this was the first researcher to perform the implant using these tumor cells, through fragmentation 51 . Subsequently, the technique was improved and the tumor cell line is easily implantable, specific for mice and grows rapidly in the host animal. The cells are maintained in the laboratory by means of weekly passages into intraperitoneal cavity of rats, when necessary the solid tumor is induced by subcutaneous or muscle and become palpable about four days post-implant and can grow to a mean diameter of 20-30 mm within 8 days 4, 13, 23, 27, 52 .
Cell maintenance
Walker-256 tumor cells are maintained by weekly passages of the intraperitoneal cavity of rats of both sexes. After the intraperitoneal application the survival of animal is of seven days 27 . For this procedure it is necessary that the animal be anesthetized and subsequently submitted to euthanasia according to the ethical principles affirmed by the Brazilian College of Animal Experimentation 53 and by the Declaration of the Rights of the Animals 54 . After euthanasia, the cells are harvested from the abdominal cavity, centrifuged, resuspended in phosphate-saline buffered, saline solution or Hank's balanced saline solution and performed the cell viability test by the Trypan blue exclusion assay in Neubauer's chamber. Subsequently, the cells are inoculated into a second animal intraperitoneally, until the application the cells need to be refrigerated 6, 10, 27, 31, 44, 45 . The ascites tumor is neither visible nor palpable. The ascitic fluid is hemorrhagic, so some authors such as Martins et al. 13 and Stipp et al. 10 reported using the solution of ethylenediaminetetraacetic acid (EDTA) as anticoagulant in the collection because of the blood present.
Few studies describe the quantity of cells used for ascites tumor induction, among the 45 papers analyzed, only 10 cited the amount used. The most commonly used amounts were 1 x 10 7 (70%) and 2 x 10 7 (30%).
Solid tumor implantation sites
The implant is performed after the Trypan blue exclusion test in the Neubauer chamber. The cells are resuspended in phosphate-saline buffer, saline solution or Hank's balanced saline and applied at the sites determined by the studies 6, 10, 13, 27, 45 added the antibiotic cell suspension (benzylpenicillin and benzetacil) in order to avoid microbial contamination.
It was observed in Table 1 that 58% (n = 26) of the studies inoculated the cells in the flanks of the animals, 33% (n = 15) in the tibia bone, 7% (n = 3) in the femur and 2% (n = 1) in the paw, using the subcutaneous via.
Tumors inoculated on the tibia and femur seek to elucidate the mechanisms and treatments related to cancer-induced bone pain. It was observed that the largest number of studies used the flank because it did not specify the primary site related to the human, it is worth mentioning that the implant is performed on both the right and left flanks (Figure 2 ). 
Cell inoculation for induction of solid tumor
According to Table 1 it was observed that the main quantity of cells used were 8 x 10 7 (20%), 1 x 10 5 (13%), 1 x 10 6 (11%) and 2 x 10 7 (11%). Thus, we observed that there is no consensus among the articles regarding the quantity of cells to be applied for the induction of solid tumors.
According to this review it was possible to verify that the experimental period was of 12 to 16 days, not obtaining a standard in the amount of days and dose for each site of implantation.
CONCLUSION
This review allowed to know the Walker-256 tumor and its peculiarities. Thus, we understood that for the ascites tumor induction the quantity 1 x 10 7 and 2 x 10 7 are used, according to the literature. It is also inferred that the main site of implantation of this cell line for induction of solid tumor is the flank and the amount of cells is not yet defined. However, the most used quantities are 8 x 10 7 and 1 x 10
5
. Suggesting that this number may vary according to the aggressiveness of the cells and experimental design. 
